Apr 23, 2021 8:20am
A shortage of vaccine staffers at Swiss CDMO Lonza may have contributed to Moderna s recent vaccine shortfalls, the biotech s CEO said. (Wikimedia Commons)
COVID-19 has put global manufacturing supply chains through the wringer: First, there were fears of a glass vial shortage; then, concerns cropped up about hold ups on plastic bags used to grow vaccine cells. Now, executives at a suite of COVID-19 heavyweights are raising flags about another pandemic resource in scarcity: people.
When Moderna last week revealed that its COVID-19 vaccine deliveries to countries like the U.K. and Canada would come in light, the mRNA player blamed the squeeze on limited “human and material resources. During a Friday summit on the pandemic vaccine scale-up, the biotech s CEO Stéphane Bancel offered some additional context: “The bottleneck right now is people.”
Industria ve escasez de materias primas como reto para producción de vacunas
rotativo.com.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rotativo.com.mx Daily Mail and Mail on Sunday newspapers.
Farmacéuticas alertan que las fronteras cerradas no dejan salir los materiales de vacunas
sinembargo.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sinembargo.mx Daily Mail and Mail on Sunday newspapers.